Amit Hasija
Chief Financial Officer and EVP, Corporate Development
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $472,770 | $991,905 |
| 2024 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $437,750 | $601,517 |
| 2023 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $437,750 | $1,006,337 |
| 2022 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $425,000 | $1,324,579 |
| 2021 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $378,667 | $1,746,964 |
| 2020 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of | $353,333 | $1,992,732 |
| 2019 | Milestone Pharmaceuticals Inc. (MIST) | Chief Financial Officer and Executive Vice President of Corporate Development | $121,250 | $2,463,312 |
Earnings-call appearances
-
Milestone Pharmaceuticals Inc. Q2 FY2026 Earnings Call2026-08-12
Milestone Pharmaceuticals Inc. (MIST)
-
Milestone Pharmaceuticals Inc. Q1 FY2026 Earnings Call2026-05-13
Milestone Pharmaceuticals Inc. (MIST)
-
TD Cowen 46th Annual Health Care Conference2026-03-03
Milestone Pharmaceuticals Inc. (MIST)